Life Sciences Solutions

Clinical trials to loss of exclusivity – achieve commercial excellence

Manufacturers in the Life Sciences space are racing against the patent clock to commercialize products in a closely regulated, dynamic marketplace. Generic competition and managed care influence are increasing. Sources of opportunity are shifting with growth concentrated in developing markets. We are working with firms across the globe to seize the opportunity in this crisis and change the game!

Health care reform will impact the US market both near term and long term. An expanding array of specialty therapies introduces new dynamics into an already complex selling environment. The traditional sales model where sales representatives detail physicians is under pressure for reasons including cost, alternative marketing channels, and increased influence of stakeholders beyond the physician. With our in-depth experience for the Life Sciences industry we support industry decisions across crucial business areas like commercial models, channel experience, incentive compensation, payer influences, sales territory structures, organized customer groups among others.

WHITEPAPER

The Evidence Supporting Sales Rep Access Restrictions To Physicians – “Where’s The Beef?”

WHITEPAPER

Impact Of State Pharmacy Drug Product Selection Laws On Patient Brand – Generic Drug Utilization

WHITEPAPER

The Changing Role Of Pharma Sales And Marketing In A Speciality Medicine Environment

WHITEPAPER

Do You Know The Answers To Your Important Territory Alignment Questions

WHITEPAPER

Challenges To Traditional Pharma Incentive Compensation Plan Design

WHITEPAPER

Measuring Sales Rep – Physician Relationship Disruption In Sales Force Optimization & Territory Alignment Analyses

WHITEPAPER

The Pricing Challenge Of Pharma’s Shift To Speciality Medicines

WHITEPAPER

Latest Pharma R&D Cost Estimates – Implications For The Expanded Use Of Commercial Analytics

WHITEPAPER

Enabling Smarter Commercial Model Experimentation

WHITEPAPER

The Agile and Adaptive Sales Territory Alignment

WHITEPAPER

Is Channel ROI dead?

WHITEPAPER

Account Based Models in an Institutional Setting

WHITEPAPER

Payer Influence on Product Performance In Pharma industry

WHITEPAPER

Creating An Effective & Motivating Incentive Compensation Plan

Learn more about Axtria Life Sciences Offerings